An AAVE token holder has suggested a "poison pill" strategy for the DAO to take control of Aave Labs' intellectual property and revenue amid concerns over a recent integration that redirected funds away from the DAO. This proposal reflects ongoing tensions regarding governance and revenue distribution between the Aave community and Aave Labs.

This article discusses the conflict between Aave DAO and Aave Labs over revenue streams and brand usage. Aave Labs has redirected funds from the DAO to private operations, raising concerns about fiduciary duties and the potential dilution of the DAO's value. The debate highlights issues around protocol governance, product monetization, and communication gaps.